Skip to main content

Market Overview

Mid-Day Market Update: Dow Jumps Over 500 Points; Immutep Shares Plummet

Share:

Midway through trading Wednesday, the Dow traded up 2.75% to 21,273.33 while the NASDAQ fell 0.07% to 7,412.91. The S&P also rose, gaining 0.86% to 2,468.46.

US reported a total of 55,200 coronavirus cases with around 800 deaths. Italy reported a total of at least 69,100 confirmed cases and 6,800 deaths, while Spain confirmed a total of over 42,000 coronavirus cases. Mainland China reported 47 new cases on Tuesday. In total, there are at least 428,400 cases of COVID-19 worldwide with over 19,100 deaths.

Leading and Lagging Sectors

Real estate shares climbed 4% on Wednesday. Meanwhile, top gainers in the sector included Seritage Growth Properties (NYSE: SRG), up 31%, and EPR Properties (NYSE: EPR), up 23%.

In trading on Wednesday, communication services shares fell 1.8%.

Top Headline

Paychex, Inc. (NASDAQ: PAYX) reported better-than-expected earnings for its third quarter, while sales missed views.

Paychex reported quarterly earnings of $0.97 per share, beating analysts’ estimates of $0.96 per share. Revenue came in at $1.12 billion, slightly missing the consensus expectations of $1.14 billion.

 

Equities Trading UP

Astrotech Corporation (NASDAQ: ASTC) shares shot up 492% to $6.57 after the company announced it is developing its BreathTest 1000 screening instrument for lung diseases including Coronavirus and Pneumonia.

Shares of T2 Biosystems, Inc. (NASDAQ: TTOO) got a boost, shooting 108% to $0.8101 after the company announced a worldwide licensing agreement to support the development of a rapid COVID-19 test developed by Hackensack Meridian Health.

Cytosorbents Corporation (NASDAQ: CTSO) shares were also up, gaining 32% to $6.08 after the company said CytoSorb has been used in more than 70 coronavirus patients to 'help treat cytokine storm and life-threatening complications such as acute respiratory distress syndrome.'

Equities Trading DOWN

Titan Medical Inc. (NASDAQ: TMDI) shares tumbled 27% to $0.154 after the company reported a $1.2 million registered direct offering.

Shares of Immutep Limited (NASDAQ: IMMP) were down 63% to $0.69 after the company announced data from the Phase 2b AIPAC study that evaluated its lead product candidate eftilagimod alpha in combination with paclitaxel, a taxane standard-of-care chemotherapy, in HER2-negative/HR+ metastatic breast cancer, which showed 63% of patients treated with the combo were progression-free at the 6-month landmark.

ThermoGenesis Holdings, Inc. (NASDAQ: THMO) was down, falling 36% to $3.1820. ThermoGenesis reported pricing of 1 million share common stock offering at $3.50 per share.

Commodities

In commodity news, oil traded down 0.8% to $23.81, while gold traded down 1.4% to $1,637.40.

Silver traded up 2.3% Wednesday to $14.59, while copper rose 0.7% to $2.1945.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 rose 1.23% the Spanish Ibex Index rose 1.07%, while Italy’s FTSE MIB Index rose 0.12%. Meanwhile, the German DAX dropped 0.25%, and the French CAC 40 rose 2.23% while UK shares rose 2.37%.

Economics

US durable goods orders rose 1.2% for February, versus economists’ expectations for a 0.8% decline.

The FHFA house price index rose 0.3% for January, versus a revised 0.7% gain in December.

U.S. crude supplies climbed 1.6 million barrels for the week ended March 20, the Energy Information Administration reported. However, analysts were projecting a gain of 2.5 million barrels. Gasoline supplies fell 1.5 million barrels, while distillate supplies slipped 700,000 barrels last week.

 

Related Articles (ASTC + CTSO)

View Comments and Join the Discussion!

Posted-In: Mid-Day Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com